Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Top Cited Papers
- 24 April 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 14 (6), 498-509
- https://doi.org/10.1016/s1473-3099(14)70036-2
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Improving antibiotic dosing in special situations in the ICUCurrent Opinion in Critical Care, 2012
- Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapyCritical Care Medicine, 2012
- Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2012
- Therapeutic drug monitoring of antimicrobialsBritish Journal of Clinical Pharmacology, 2011
- Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patientsJournal of Antimicrobial Chemotherapy, 2010
- Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric AnalysisAntimicrobial Agents and Chemotherapy, 2010
- fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection modelsJournal of Antimicrobial Chemotherapy, 2010
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsisInternational Journal of Antimicrobial Agents, 2009
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006